The Tunnel Technique and Free Gingival Graft in Gingival Recessions Treatment

May 6, 2024 updated by: Universidade Federal de Alfenas

Comparative Evaluation of the Tunnel Technique and Free Gingival Graft in Gingival Recessions Treatment: Randomized Controlled Trial

The present study aims to compare the tunnel technique/laterally closed tunnel technique and the FGG technique in the treatment of isolate/multiple GR in the anterior region of the mandible. Furthermore, it is proposed to evaluate the effect of a gel based on hyaluronic acid and green tea on the healing of the donor area after the removal of FGG from the palate. This work is expected to contribute to the still uncertain literature on the effectiveness of the tunnel technique as an alternative to the use of FGG in the treatment of multiple GR in the mandible.

Study Overview

Detailed Description

Free gingival graft (FGG) is a simple technique considered the most effective procedure to obtain gingival augmentation in sites with a minimal amount of keratinized gingiva. However, the abscence of chromatic integration and unsatisfactory texture of the graft after healing prevent its use in areas with high aesthetic demand. In this context, the tunnel technique (multiple gingival recessions [GR]) and the laterally closed tunnel technique (isolated GRs in the mandible) have been proposed as an alternative to the use of FGG in the treatment of GRs in the mandible. The present study aims to compare the tunnel technique/laterally closed tunnel technique and the FGG technique in the treatment of isolate/multiple GR in the anterior region of the mandible. Furthermore, it is proposed to evaluate the effect of a gel based on hyaluronic acid and green tea on the healing of the donor area after the removal of FGG from the palate. Sixty participants presenting isolate/multiple Miller Class I, II, or III GR [Recession type (RT) 1 or RT2] in the anterior region of the mandible will be included in the present study. Regarding the treatment of GR, participants will be divided into four groups: (1) Test Group 1 (T1) (n=15): multiple GR in the anterior region of the mandible treated with the tunnel technique; (2) Test Group 2 (T2) (n=15): isolate GR in the anterior region of the mandible treated with the laterally closed tunnel technique; (3) Control Group 1 (C1) (n=15): multiple GRs in the anterior region of the mandible will be treated using the FGG technique and (4) Control Group 2 (C2) (n=15): isolate GRs in the anterior region of the mandible will be treated using the FGG technique. Regarding the treatment of the donor area, the same participants will be divided into two groups: (1) Gel Group (G) (n=30): the donor area on the palate will be treated using hyaluronic acid gel and green tea applied by the participant 3 times a day for 7 days; (2) Clot Group (CO) (n=30): No material will be placed in the donor area, only the clot will be kept in position by means of sutures. Periodontal clinical parameters will be evaluated in the receiving area at the beginning of the study and after 1, 3, 6 and 12 months postoperatively. In the donor area, the percentage of wound closure, the epithelialized surface area and the color of the palatine mucosa will be evaluated in both groups after 3, 7, 15 and 30 days. The visual analogue scale (VAS) of pain (donor and recipient area) and aesthetic (recipient area) will be used to assess the participant's perception of the treatment used.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Minas Gerais
      • Alfenas, Minas Gerais, Brazil, 37130-013
        • Recruiting
        • Universidade Federal de Alfenas
        • Contact:
        • Principal Investigator:
          • Suzane C Pigossi, PhD
        • Sub-Investigator:
          • Guilherme PL de Oliveira, PhD
        • Sub-Investigator:
          • Jovânia A Oliveira
        • Sub-Investigator:
          • Marcela I Silveira
        • Sub-Investigator:
          • Roberta O Alves

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age between 18 and 60 years old;
  • Present isolated (≥4mm) or multiple GR in the anterior region of the mandible (tooth 33 to 43) Miller Class I, II or III (87) (or Recession type (RT) 1 or RT2);
  • Systemically healthy with no contraindications for periodontal surgery;
  • Probing depth of less than 3mm at the sites involved;
  • Selected teeth properly positioned, free from endodontic treatment, any type of restorative treatment, caries or non-carious cervical lesion

Exclusion Criteria:

  • Participants who use tobacco or other types of drugs;
  • Participants submitted to periodontal treatment in the last 6 months;
  • Pregnant participants;
  • Participants who did not accept to return to follow-ups;
  • Participants who used antibiotics, corticosteroids, chemotherapy, immunomodulators or others that modify the periodontal therapy results during the last 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Test Group 1 (T1)
Multiple gingival recessions in the anterior region of the mandible treated with the tunnel technique.
Intrasulcular incisions on the buccal surface were made using a n°15 C blade, preserving the integrity of the papillae. The incision was extended to the adjacent tooth on both sides of the multiple recessions. Dissection of the entire buccal aspect was performed as a partial-thickness flap using sharp tunnel elevators preserving the papillae. The flap was extended beyond the mucogingival junction and under each papilla allowing a tension-free flap mobilization in the coronal direction. The connective tissue graft was placed in the tunnel and was stabilized using absorbable suspensory sutures. The mobilized mucous flap was advanced coronally to the cemento enamel junction, and suspensory sutures were stitched.
The connective tissue graft will be obtained by the free gingival graft technique for all groups (T1, T2, T3 and T4). The mold of the prepared receiving area will be performed using sterile aluminum foil. The mold will be transferred to the donor area on the palate and the edges of the mold delimited with a scalpel blade. Deeper incisions will be made on the edges with the scalpel perpendicular to the palate, aiming to obtain a graft approximately 1.5 mm thick. With the scalpel blade parallel, the graft will be removed (epithelium and connective graft) maintaining its uniform thickness. For T1 and T2, the free gingival graft will be de-epithelialized. In donor area, a hyaluronic acid gel and green tea will be applied by the participant 3 times a day for 7 days (gel group) or no material will be placed in the donor area and the clot will be kept in position by means of sutures (clot group).
Experimental: Test Group 2 (T2)
Isolate gingival recessions in the anterior region of the mandible treated with the laterally closed tunnel technique.
The connective tissue graft will be obtained by the free gingival graft technique for all groups (T1, T2, T3 and T4). The mold of the prepared receiving area will be performed using sterile aluminum foil. The mold will be transferred to the donor area on the palate and the edges of the mold delimited with a scalpel blade. Deeper incisions will be made on the edges with the scalpel perpendicular to the palate, aiming to obtain a graft approximately 1.5 mm thick. With the scalpel blade parallel, the graft will be removed (epithelium and connective graft) maintaining its uniform thickness. For T1 and T2, the free gingival graft will be de-epithelialized. In donor area, a hyaluronic acid gel and green tea will be applied by the participant 3 times a day for 7 days (gel group) or no material will be placed in the donor area and the clot will be kept in position by means of sutures (clot group).
Intrasulcular incisions on the buccal surface were made using a n°15 C blade, preserving the integrity of the papillae. The tunnel elevators were mobilized apically beyond the mucogingival line and extended medially and distally from the recession defect by undermining the facial surface of the interdental papillae. The insertion of muscles and fibers must be removed until a tension-free flap is obtained in the mesial, apical and distal directions. The preparation of the flap will be done carefully to avoid rupture of the papillae and perforation of the flap. As a result of this procedure, the mesial and distal margins of the flap must be brought together without tension to cover the exposed part of the root surface. The connective tissue graft was placed in the tunnel and was fixed mesially and distally at the inner aspect of the flap. Margins of the flap were pulled together over the graft and sutured with interrupted sutures.
Active Comparator: Control Group 1 (C1)
Multiple gingival recessions in the anterior region of the mandible will be treated using the free gingival graft technique.
The connective tissue graft will be obtained by the free gingival graft technique for all groups (T1, T2, T3 and T4). The mold of the prepared receiving area will be performed using sterile aluminum foil. The mold will be transferred to the donor area on the palate and the edges of the mold delimited with a scalpel blade. Deeper incisions will be made on the edges with the scalpel perpendicular to the palate, aiming to obtain a graft approximately 1.5 mm thick. With the scalpel blade parallel, the graft will be removed (epithelium and connective graft) maintaining its uniform thickness. For T1 and T2, the free gingival graft will be de-epithelialized. In donor area, a hyaluronic acid gel and green tea will be applied by the participant 3 times a day for 7 days (gel group) or no material will be placed in the donor area and the clot will be kept in position by means of sutures (clot group).
In the recipient area, a marginal horizontal linear incision will be made in the mucogingival junction with a n°15 C blade, creating a partial thickness flap, keeping the periosteum intact. The horizontal dimension of the receiving area will be determined according to the mesiodistal extension of the area without keratinized gingiva. All mobile soft tissues, including epithelium, connective tissue and muscle fibers will be removed from the donor area using scissors to ensure stability in the recipient area. The connective tissue graft will be obtained by the free gingival graft technique and will be sutured in the recipient area.
Active Comparator: Control Group 2 (C2)
Isolate gingival recessions in the anterior region of the mandible will be treated using the free gingival graft technique.
The connective tissue graft will be obtained by the free gingival graft technique for all groups (T1, T2, T3 and T4). The mold of the prepared receiving area will be performed using sterile aluminum foil. The mold will be transferred to the donor area on the palate and the edges of the mold delimited with a scalpel blade. Deeper incisions will be made on the edges with the scalpel perpendicular to the palate, aiming to obtain a graft approximately 1.5 mm thick. With the scalpel blade parallel, the graft will be removed (epithelium and connective graft) maintaining its uniform thickness. For T1 and T2, the free gingival graft will be de-epithelialized. In donor area, a hyaluronic acid gel and green tea will be applied by the participant 3 times a day for 7 days (gel group) or no material will be placed in the donor area and the clot will be kept in position by means of sutures (clot group).
In the recipient area, a marginal horizontal linear incision will be made in the mucogingival junction with a n°15 C blade, creating a partial thickness flap, keeping the periosteum intact. The horizontal dimension of the receiving area will be determined according to the mesiodistal extension of the area without keratinized gingiva. All mobile soft tissues, including epithelium, connective tissue and muscle fibers will be removed from the donor area using scissors to ensure stability in the recipient area. The connective tissue graft will be obtained by the free gingival graft technique and will be sutured in the recipient area.
Experimental: Gel Group (G)
The donor area on the palate will be treated using hyaluronic acid gel and green tea applied by the participant 3 times a day for 7 days.
The connective tissue graft will be obtained by the free gingival graft technique for all groups (T1, T2, T3 and T4). The mold of the prepared receiving area will be performed using sterile aluminum foil. The mold will be transferred to the donor area on the palate and the edges of the mold delimited with a scalpel blade. Deeper incisions will be made on the edges with the scalpel perpendicular to the palate, aiming to obtain a graft approximately 1.5 mm thick. With the scalpel blade parallel, the graft will be removed (epithelium and connective graft) maintaining its uniform thickness. For T1 and T2, the free gingival graft will be de-epithelialized. In donor area, a hyaluronic acid gel and green tea will be applied by the participant 3 times a day for 7 days (gel group) or no material will be placed in the donor area and the clot will be kept in position by means of sutures (clot group).
Active Comparator: Clot Group (CO)
No material will be placed in the donor area, only the clot will be kept in position by means of sutures.
The connective tissue graft will be obtained by the free gingival graft technique for all groups (T1, T2, T3 and T4). The mold of the prepared receiving area will be performed using sterile aluminum foil. The mold will be transferred to the donor area on the palate and the edges of the mold delimited with a scalpel blade. Deeper incisions will be made on the edges with the scalpel perpendicular to the palate, aiming to obtain a graft approximately 1.5 mm thick. With the scalpel blade parallel, the graft will be removed (epithelium and connective graft) maintaining its uniform thickness. For T1 and T2, the free gingival graft will be de-epithelialized. In donor area, a hyaluronic acid gel and green tea will be applied by the participant 3 times a day for 7 days (gel group) or no material will be placed in the donor area and the clot will be kept in position by means of sutures (clot group).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recession depth
Time Frame: Change from baseline recession depth at 1, 3, 6 and 12 months
Distance between cemento-enamel junction to free gingival margin.
Change from baseline recession depth at 1, 3, 6 and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recession width
Time Frame: Change from baseline recession width at 1, 3, 6 and 12 months
Mesio-distal extent of gingival recession
Change from baseline recession width at 1, 3, 6 and 12 months
Probing depth
Time Frame: Change from baseline probing depth at 1, 3, 6 and 12 months
Distance between free gingival margin to the bottom of the sulcus.
Change from baseline probing depth at 1, 3, 6 and 12 months
Clinical attachment level
Time Frame: Change from baseline clinical attachment level at 1, 3, 6 and 12 months
Distance between cemento-enamel junction to the bottom of the sulcus.
Change from baseline clinical attachment level at 1, 3, 6 and 12 months
Keratinized tissue width
Time Frame: Change from baseline keratinized tissue width at 1, 3, 6 and 12 months
Distance between the most apical point on free gingival margin to the mucogingival junction.
Change from baseline keratinized tissue width at 1, 3, 6 and 12 months
Gingival thickness
Time Frame: Change from baseline gingival thickness at 6 and 12 months
The measurements were registered at the mid-buccal aspect of the tooth using a endodontic file. The distance between the marker and the tip of the file will be determined using a digital caliper.
Change from baseline gingival thickness at 6 and 12 months
Gingival margin position
Time Frame: Change from baseline gingival margin position at 1, 3, 6 and 12 months
Distance from a reference point performed on the customized stent to the gingival margin.
Change from baseline gingival margin position at 1, 3, 6 and 12 months
Graft thickness after removal
Time Frame: Baseline
Graft thickness will be assessed immediately after removal using a endodontic file in the middle of the graft. The distance between the marker and the tip of the file will be determined using a digital caliper.
Baseline
Graft thickness immediately before suture
Time Frame: Baseline
The thickness of the graft immediately before suturing will be evaluated after de-epithelialization (in the T group) and the removal of adipose tissue when present in both groups in the middle of the graft. The distance between the marker and the tip of the file will be determined using a digital caliper.
Baseline
Height of keratinized tissue in graft
Time Frame: Change from immediate postoperative height of keratinized tissue in graft at 1, 3, 6 and 12 months
Apico-coronal dimension of the graft measured at the stent mark using the periodontal probe.
Change from immediate postoperative height of keratinized tissue in graft at 1, 3, 6 and 12 months
Width of keratinized tissue in graft
Time Frame: Change from immediate postoperative width of keratinized tissue in graft at 1, 3, 6 and 12 months
Mesio-distal dimension of the graft in the most coronal portion of the graft using the periodontal probe.
Change from immediate postoperative width of keratinized tissue in graft at 1, 3, 6 and 12 months
Graft contraction
Time Frame: Change from immediate postoperative graft contraction at 1, 3, 6 and 12 months
Graft areas will be calculated by multiplying the height and width of keratinized tissue in graft.
Change from immediate postoperative graft contraction at 1, 3, 6 and 12 months
Percentage of wound reduction by photographic image
Time Frame: Change from 3 days percentage of wound reduction by photographic image at 7, 15 and 30 days
The millimeter periodontal probe will be positioned next to the wound at the time of obtaining the photos to calibrate the image analysis software that will be used to calculate the total area of the wound in donor region.
Change from 3 days percentage of wound reduction by photographic image at 7, 15 and 30 days
Percentage of Wound Reduction by clinical measurement
Time Frame: Change from 3 days percentage of wound reduction by clinical measurement at 7, 15 and 30 days
The height and width of the wound will be determined using the periodontal probe.
Change from 3 days percentage of wound reduction by clinical measurement at 7, 15 and 30 days
Epithelized surface area
Time Frame: Change from 3 days epithelized surface area at 7, 15 and 30 days
The epithelialization analysis will be performed using 3% oxygen peroxide to observe the presence of blistering in the wound. The absence of epithelialization will be characterized as blistering after contact of oxygen peroxide with the wound. This parameter will be noted dichotomously (presence/absence of bubbles), being noted as yes or no, respectively, in the participant's form.
Change from 3 days epithelized surface area at 7, 15 and 30 days
Palatal mucosa color
Time Frame: Change from 3 days palatal mucosa color at 7, 15 and 30 days
The color of the palatal mucosa will be evaluated by the visual analogue scale (VAS) in comparison with the color of the adjacent and opposite mucosa. In this evaluation, on a horizontal scale, 0 points will represent lack of color correspondence, 50 points will represent average correspondence and 100 points will represent excellent color correspondence with the adjacent tissues.
Change from 3 days palatal mucosa color at 7, 15 and 30 days
Postoperative complications
Time Frame: 3 days
Presence of bleeding, swelling, infection and necrosis in the donor area will be recorded
3 days
Postoperative complications
Time Frame: 7 days
Presence of bleeding, swelling, infection and necrosis in the donor area will be recorded
7 days
Landry index
Time Frame: Change from 3 days landry index at 7 and 30 days
Classify the degree of repair based on erythema, presence of granulation tissue, bleeding/suppuration, and epithelialization in the recipient area. A score of 1 to 5 is given, where 1 is associated with a very poor/inadequate repair process and 5 is excellent.
Change from 3 days landry index at 7 and 30 days
Root coverage esthetic score (RES)
Time Frame: 6 months
The RES system evaluates five variables of the recipient area including: gingival margin level, marginal tissue contour, soft tissue texture, JMG alignment and gingival color. Zero, 3 or 6 points will be used to assess the position of the gingival margin, while a score of 0 or 1 point will be used for each of the other variables. The ideal aesthetic score will be 10.
6 months
Root coverage esthetic score (RES)
Time Frame: 12 months
The RES system evaluates five variables of the recipient area including: gingival margin level, marginal tissue contour, soft tissue texture, JMG alignment and gingival color. Zero, 3 or 6 points will be used to assess the position of the gingival margin, while a score of 0 or 1 point will be used for each of the other variables. The ideal aesthetic score will be 10.
12 months
Visual Analogue Scale (VAS) for pain
Time Frame: Change from 3 days VAS scale for pain at 7, 12 and 30 days
The perception of pain will be recorded using the VAS scale at the operated sites. Participants will record the level of pain in the recipient and donor areas after the procedure on a horizontal scale, where the left endpoint will mean no pain (0), the midpoint of mean pain (50 ) and the right outcome severe pain (100).
Change from 3 days VAS scale for pain at 7, 12 and 30 days
Presence or absence of dentin sensitivity
Time Frame: Change from 1 month dentin sensitivity at 3, 6 and 12 months
Determined from the participants' responses regarding the presence or absence of sensitivity in the cervical sites. For this, it will be asked if the participant has or not dentin sensitivity after a cold or air stimulus.
Change from 1 month dentin sensitivity at 3, 6 and 12 months
Visual Analogue Scale (VAS) for esthetics
Time Frame: 6 months
Participants will be asked to express their overall satisfaction with treatment outcomes on a VAS scale, where the left endpoint will mean not at all satisfied (0), the midpoint reasonably satisfied (50) and the right endpoint extremely satisfied. satisfied (100).
6 months
Visual Analogue Scale (VAS) for esthetics
Time Frame: 12 months
Participants will be asked to express their overall satisfaction with treatment outcomes on a VAS scale, where the left endpoint will mean not at all satisfied (0), the midpoint reasonably satisfied (50) and the right endpoint extremely satisfied. satisfied (100).
12 months
Analgesics consumption
Time Frame: 7 days
The consumption of analgesics by the participants in the first 7 postoperative days will also be recorded.
7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Suzane C Pigossi, PhD, Alfenas Federal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 5, 2021

Primary Completion (Estimated)

November 5, 2025

Study Completion (Estimated)

November 5, 2025

Study Registration Dates

First Submitted

January 31, 2022

First Submitted That Met QC Criteria

February 25, 2022

First Posted (Actual)

March 8, 2022

Study Record Updates

Last Update Posted (Actual)

May 8, 2024

Last Update Submitted That Met QC Criteria

May 6, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gingival Recession

Clinical Trials on Tunnel technique

Subscribe